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Duck enteritis virus UL54 is an IE protein
primarily located in the nucleus
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Abstract
Background: The UL54 protein of Duck Enteritis Virus (DEV) is a homolog of herpes simplex virus-1 (HSV-1)
immediate-early infectious cell protein 27 (ICP27), a multifunctional protein essential for viral infection. Nonetheless,
there is little information on the UL54 protein of DEV.
Methods: The UL54 gene was cloned into the pPAL7 vector, and the recombinant protein, expressed in the
E. coli Rosetta, was used to produce a specific antibody. Using this antibody, Western blotting and indirect
immunofluorescence analysis (IFA) were used to analyze the expression level and intracellular localization,
respectively, of UL54 in DEV-infected cells at different times. Real-time quantitative reverse transcription PCR
(RT-PCR) and the pharmacological inhibition test were utilized to ascertain the kinetic class of the UL54 gene.
Results: UL54 was expressed as a fusion protein of approximately 66.0 kDa using the prokaryotic expression
system, and this protein was used to generate the specific anti-UL54 antibody. The UL54 protein was initially
diffusely distributed throughout the cytoplasmic region; then, after 2 h, it gradually distributed into the nucleus,
peaking at 24 h, and complete localization to the nucleus was observed thereafter. The UL54 transcript was
detected as early as 0.5 h, and peak expression was observed at 24 h. The UL54 gene was insensitive to the DNA
polymerase inhibitor Ganciclovir (GCV) and the protein synthesis inhibitor Cycloheximide (CHX), both of which
confirmed that UL54 was an immediate early gene.
Conclusions: The DEV UL54 gene was expressed in a prokaryotic expression system and characterized for
expression level, intracellular localization and gene kinetic class. We propose that these results will provide the
foundation for further functional analyses of this gene.
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Background
Duck enteritis virus (DEV), a member of the alpha-
herpes virus subfamily, induces an acute, hemorrhagic
disease resulting in significant economic losses in
waterfowl due to high mortality and low laying rates.
As an alpha-herpes virus, DEV might share a similar
genomic structure with Herpes simplex virus types 1
and 2 (HSV-1 and HSV-2), Pseudorabies virus (PRV),
Varicella-zoster virus (VZV), Equine herpes virus types 1
and 4 (EHV-1 and EHV-4), and Bovine herpes virus type 1
(BHV-1). The genome is a linear double-stranded DNA
molecule divided into a unique long region (UL) and a
unique short region (US) flanked by an internal short
repeat (IRS) and a short terminal repeat (TRS) [1].
During infection, the genes are expressed in a sequen-
tial cascade, termed immediate early (IE), early (E),
and late (L) phases. The IE gene is immediately tran-
scribed upon infection, without other proteins. The
early gene is transcribed prior to viral DNA replication
in an IE protein-dependent manner. Transcription of
the late gene begins after the synthesis of DNA and
viral protein is onset.
With the research of etiology, pathology, immunology,
diagnostics, prevention and treatment, more information
about DEV genes has been reported, except for UL54,
which was predicted to encode a 51.75 kDa protein
* Correspondence: chenganchun@vip.163.com; mshwang@163.com
1Avian Diseases Research Center, College of Veterinary Medicine, Sichuan
Agricultural University, Wenjiang, Chengdu City, Sichuan 611130, P.R. China
Full list of author information is available at the end of the article
© 2015 Liu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liu et al. Virology Journal  (2015) 12:198 
DOI 10.1186/s12985-015-0424-z
of 458 AA with 56 % homology to the corresponding
HSV-1 protein ICP27. ICP27 is a conserved and multi-
functional nuclear protein that translocates between the
nucleus and the cytoplasm based on crucial nuclear
localization (NLS) and nuclear export signal (NES) [2–8].
Furthermore, ICP27 has been implicated in viral replica-
tion, gene expression [9–16], apoptosis [17, 18] and host
immunization reactions [19–22], all of which promote
infection.
In the present study, UL54 was expressed as a tagged-
protein with a molecular mass of apparent 66.0 kDa
using an Escherichia coli expression system. Subse-
quently, we generated an UL54-specific antibody to
analyze the expression level and intracellular localization
of UL54 protein in DEV-infected cells. The transcript
temporal class and susceptibility to CHX and GCV were
characterized to demonstrate UL54 as an immediate
early gene.
Fig. 1 Analysis of UL54 protein expression. a The pPAL7 and pPAL7-UL54 were induced to express protein in E. coli Rosetta, BL21 (DE3), BL21
(pLysS). (−) and (+) represent incubation without and with IPTG, respectively. b, c, d UL54 protein was expressed at different temperatures
(25, 30, and 37 °C), induction times (2, 3, 4, 5 and 6 h), and IPTG concentrations (0.2, 0.4, 0.6, 0.8, and l.0 mM)
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Results and discussion
The DEV UL54 protein was expressed in an E. coli
expression system
The UL54 gene was cloned into vector pPAL7 and
expressed under varying conditions, including different
E. coli host cells, inducer concentrations, induction tem-
peratures and induction durations (Fig. 1). The products
were analyzed using SDS-PAGE, and there was no de-
tectable UL54 gene expression in E. coli cells containing
pPAL7 alone or non-induced pPAL7-UL54. However, a
distinct band with a molecular mass of approximately
66.0 kDa (Profanity Exact-tag = 8.0 kDa) was visible
when pPAL-UL54 expression was induced using IPTG
in E. coli Rosetta at 37 °C. Furthermore, the expression
of the UL54-Profinity Exact fusion protein was optimal
when induced using 0.6 mM IPTG for 6 h.
Subsequently, the UL54 protein was expressed in E. coli
Rosetta under optimized conditions and purified through
gel and electric elution (Fig. 2a). The product was applied
to generate the anti-UL54 polyclonal antibody (Fig. 2b),
which was used for further studies. The protein was con-
firmed through Western blot analysis, and the results indi-
cated that the rabbit anti-DEV antibody reacted with
recombinant UL54 protein, revealing a specific band cor-
responding to a fusion protein of 66.0 kDa (Fig. 2c), con-
sistent with the SDS-PAGE result showing a slightly
higher than the predicted molecular mass of the UL54
protein. Notably, the amino acid composition might be
responsible for the observed deviation.
The DEV UL54 is an immediate early gene
Western blotting was used to detect DEV UL54 protein
(Fig. 2d), which was initially detected at 2 h, and grad-
ually increased expression was detected until 24 h, at
which the highest expression level was observed.
Subsequently, we investigated the relative expression
of the DEV UL54 gene in DEV-infected DEF cells at
different time points using quantitative RT-PCR, the
Fig. 2 Preparation of anti-UL54 polyclonal antibody and UL54 expression analysis in DEV-infected cells. a UL54 protein was purified through gel
and electric elution. b The anti-UL54 protein serum was cursorily purified using saturated ammonium sulfate. c Western blot analysis of the UL54
protein using rabbit anti-DEV-positive serum (lane 1) and rabbit negative control serum (lane 2). d Western blotting was used to analyze the
lysates of DEV-infected DEFs harvested at different time points
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most sensitive technique currently used to analyze
gene expression [23]. Standard curves, plotting plas-
mid copy number against the Ct values for the UL54 gene
(Y = −3.280X + 13.943) and B-actin (Y = −3.268X + 0.173),
were established to evaluate the efficiency of the assays
(Fig. 3c), and the results were confirmed by the approxi-
mately identical amplification efficiency of the UL54 gene
(101.8 %) and B-actin (102.3 %), with the correlation coef-
ficients of 1.00 (Fig. 3a). Notably, the specificity of the pri-
mer sets was verified using a melting curve (Fig. 3b).
Subsequently, total RNA was isolated, and after assessing
the integrity, the RNA sample was reverse transcribed to
cDNA, followed by RT-PCR and data processing to
analyze the UL54 transcript levels. The results showed
transcript expression as early as 0.5 h, and gradually in-
creased, peaking at 24 h (Fig. 4a), confirming the results of
the translation studies. Thus, these results suggested that
the UL54 protein is an early gene product.
Moreover, we determined that UL54 is one of the sev-
eral immediate-early genes based on the insensitivity of
this gene to CHX and GCV (Fig. 4b). The positive and
negative lanes represent uninfected and infected DEF
cells without any treatment, respectively. Homologs of
UL54 in other herpes viruses, such as PRV, BHV-1 and
EHV-1, are synthesized with early kinetics [24–26].
The IE genes of DNA viruses encode regulatory pro-
teins critical for viral infection. The five IE genes of
HSV-1, namely ICP0, ICP4, ICP22, ICP27, and ICP47,
have been identified, and among these [27, 28], ICP27
(UL54) is the most extensively studied for its potential
regulation activity. However, an extreme degree of UL54
homology (29.5–43.1 %) had been observed in alpha-
herpes virus counterparts, such as HSV-1, PRV, EHV-1,
EHV-4, HSV-2, and VZV. High conservation and IE
kinetics suggest that DEV UL54 might share a similar
structure and regulatory function with HSV-1 ICP27,
although this hypothesis requires additional studies.
The DEV UL54 protein showed nuclear localization
The intracellular distribution of DEV UL54 protein was
confirmed through IFA using rabbit anti-UL54 serum.
As shown in Fig. 5, UL54 protein-specific fluorescence
was primarily located in the cytoplasmic region at 2, 4,
and 6 h post-infection, and this fluorescence was grad-
ually transferred to the nucleus. At 48 h post-infection,
almost all UL54-specific fluorescence appeared in the
nucleus, and subsequently, this signal became sparser
and weaker following cytoplasmic disintegration. No
fluorescence was observed in mock-infected cells. This
result was consistent with the findings of previous bio-
informatics analyses, showing that the UL54 protein is
primarily localized to the nucleus [29]. The nuclear im-
port of proteins is an essential step in regulating gene
expression and the replication cycle, suggesting that
Fig. 3 PCR amplification curves (a), melting curves (b) and standard
curves (c) for B-actin and UL54
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DEV UL54 might have vital functions similar to HSV-
1ICP27, which is primarily located in the nucleus and
indispensable for viral infection [8].
Conclusion
DEV UL54 was expressed as an approximately 66.0 kDa
fusion protein in an E. coli expression system and subse-
quently identified as an immediate early gene that pri-
marily localizes to the nucleus. More efforts are needed
to elaborate the roles of UL54 in DEV infection.
Methods
Viruses and cells
DEV CHV strain was separated and preserved in the la-
boratory. Monolayer cultures of duck embryo fibroblast
(DEF) cells were grown in Modified Eagle’s medium
(MEM) supplemented with 10 % newborn calf serum
(NBS) at 37 °C in a 5 % CO2 humidified incubator.
Prokaryotic expression
The UL54 gene was amplified from the DEV genome
and cloned into the pPAL7 vector, generating the recom-
binant plasmid pPAL-UL54, which was transformed into
E. coli strains for subsequent protein expression [30, 31].
Subsequently, the colonies were picked, and expression
was induced using isopropyl-B-thiogalactopyranoside
(IPTG). The effects of different host cells (E. coli
Rosetta, BL21 (DE3), and BL21 (pLysS)), inducer con-
centrations (0.2–1 mM), induction temperatures (25, 30,
and 37 °C) and induction durations (2, 3, 4, 5, and 6 h)
were examined to optimize the conditions for the
highest level of UL54 protein expression. After IPTG
induction cells were collected at different time point
through cold centrifugation, and the products were
determined through SDS-PAGE after disruption using
cold sonication.
Preparation of the polyclonal antibody
The UL54 protein was expressed and purified through
gel and electric elusion, and used to generate a
polyclonal antibody after purification through gel and
electric elution. Approximately 0.5 mg of UL54 emul-
sified in complete Freund’s adjuvant and used to
immunize eight rabbits through intradermal injec-
tions. Subsequent booster doses of 0.75 and 1.0 mg
were prepared in incomplete Freund’s adjuvant, and
the protein was administered after 2 and 3 weeks,
respectively, using subcutaneous injections. Approxi-
mately 0.5 mg of UL54 protein was injected per
rabbit. To collect the antibody, the rabbits were bled
through an ear vein at 1 week after the last immunization.
The antiserum was harvested, and a preliminary puri-
fication was conducted using saturated ammonium
sulfate [32].
Western blotting
The UL54 protein expression in E. coli Rosetta and DEF
cells were detected using western blotting with rabbit
anti-DEV and anti-DEV UL54 protein antibodies, re-
spectively, as the primary antibodies [33]. A standard
protocol was performed after the proteins were sepa-
rated through electrophoresis on 12 % SDS-PAGE gels
and transferred to polyvinylidene fluoride (PVDF) mem-
branes using a semi-dry transfer cell apparatus. The
membranes were blocked with PBS buffer containing
1 % BSA for 1 h and subsequently incubated with the
diluted primary antibody for an additional 1 h. The
membrane was washed for 30 min with 1× PBS contain-
ing 0.05 % Tween-20 and subsequently incubated with
goat anti-rabbit HRP-labeled IgG secondary antibodies
for 30 min. After washing, the membrane was developed
using a DAB kit as previously described.
Real Time PCR (RT-PCR)
Total RNA was isolated from DEV-infected DEF cells
at different time points post-infection (0.5, 1, 2, 4, 6,
8, 12, 16, 24, 36, and 72 h) using Trizol, followed by
DNase treatment during the RNA extraction. A sam-
ple of the total RNA was reverse-transcribed to cDNA
using M-MLV (Moloney Murine Leukemia virus) reverse
Fig. 4 Transcription phase analysis of the UL54 gene. a Relative transcript levels of the DEV UL54 gene at different time points. b The
pharmacological inhibition test showed that UL54 is an immediately early gene
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transcriptase after assessing the quality of the RNA using
electrophoresis with 1 % agarose. Subsequently, real-time
PCR was performed in a 20-μl-reaction volume containing
10 μL of SYBR Green Super Mix, 1 μLof each primer,
1 μL of cDNA, and 7 μL of ultrapure water. The thermal
cycling procedure included initial denaturation for
1 min at 95 °C, followed by 45 cycles of denaturation
at 95 °C for 5 s, annealing at 59 °C for 20 s and extension
at 72 °C for 25 s. Triplicate experiments were performed
to analyze gene expression of UL54 and B-actin, and the
relative transcription level of the DEV UL54 gene was cal-
culated using the 2-ΔCt method simplified from the 2-ΔΔCt
method.
To evaluate the efficiency of each assay, standard
curves were constructed, amplifying ten-fold serial dilu-
tions of pPAL7-UL54 and pGM-T/B-actin [34, 35].
Pharmacological inhibition reaction
Pharmacological inhibition was performed to confirm
the DEV UL54 gene expression patterns. Total RNA was
isolated from DEV-infected DEF cells incubated with
GCV or CHX at 24 h post-infection and subsequently
reverse transcribed into cDNA. The cDNA was used for
subsequent PCR analysis, and the product was identified
using a 1 % agarose gel.
Indirect immune-fluorescence assay (IFA)
IFA was conducted using a standard procedure [36].
Briefly, DEV-infected DEF cells were plated onto cov-
erslips and fixed with 4 % paraformaldehyde for
30 min at 0, 2, 4, 6, 8, 12, 24, 36, 48, 60 and 72 h
post-infection. The fixed cells were permeabilized
with 0.5 % Triton X-100 and incubated for 30 min in
Fig. 5 Dynamic intracellular localization of the UL54 protein during DEV infection
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5 % BSA at 37 °C. The anti-UL54 antibody and
FITC-conjugated goat anti-rabbit IgG were used as
primary and secondary antibodies, respectively, and
the blots were sequentially incubated for 1 h. Subse-
quently, the cells were treated with 4’6-diamidino-2-
phenylindole (DAPI) for 10 min to stain the nucleus.
The images were captured using a fluorescence micro-
scope after the coverslips were sealed with glycerin buffer
onto glass slides.
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